Minimally Invasive Knee Replacement Outcomes (MIKRO) Study

NCT ID: NCT00633113

Last Updated: 2013-04-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

131 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-11-30

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate and compare the clinical, radiographic (x-ray) and cost effectiveness outcomes (cost relative to risks and benefits) of two different minimally invasive knee joint replacement surgical techniques. The primary study hypothesis is that in comparing total knee replacement performed with the two different surgical techniques that respect four minimally invasive surgery principles (low-profile instrumentation, "minimally invasive" incision, overall minimal knee surgical intervention), a faster return to function will result when the technique does not incise the tendon.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study does not include financial compensation for treatments involved.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

\- Medial Parapatellar Arthrotomy (MPPA) technique

Group Type ACTIVE_COMPARATOR

MPPA

Intervention Type PROCEDURE

\- Medial Parapatellar Arthrotomy

2

\- Subvastus (SV) technique

Group Type ACTIVE_COMPARATOR

SV

Intervention Type PROCEDURE

\- Subvastus Technique

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MPPA

\- Medial Parapatellar Arthrotomy

Intervention Type PROCEDURE

SV

\- Subvastus Technique

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presence of severely symptomatic knee osteoarthritis that has failed non- operative treatment
* Males and non-pregnant females, 35-85 years of age at the time of surgery
* ASA class 1 or 2
* Procedure will not require computer navigation
* Patient/Surgeon has not requested another implant
* Patient has signed an IRB approved study consent form
* Patient is able and willing to actively participate in post-operative rehabilitation program
* Patient understands study requirements
* Patient is willing to comply with follow-up visits and diary documentations
* Patient is capable of independent ambulation

Exclusion Criteria

* Skeletal immaturity
* More than 10 degrees of valgus or varus deformity as measured from a weight bearing AP alignment view
* Patients with bilateral knee osteoarthritis who are considering a simultaneous bilateral procedure
* Bone or ligament insufficiency that requires the use of augments or stems, or constrained component
* Daily pre-operative use of narcotic pain medication
* Prior knee arthroplasty
* Patient is a prisoner
* Patient has had prior tibial tubercle osteotomy
* Patient's surgical knee would require removal of hardware prior to TKA
* Patient has \< 95 degrees flexion pre-operatively
Minimum Eligible Age

35 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role collaborator

Dartmouth-Hitchcock Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ivan M Tomek, MD

Role: PRINCIPAL_INVESTIGATOR

Dartmouth-Hitchcock Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MIKRO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.